Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty
This study has been completed.
Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborator:
Instituto de Salud Carlos III
Information provided by:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier:
NCT00866268
First received: March 19, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Principal hypothesis:
A low suction drainage (-50 mmHg) reduce a 25% the blood loss with respect a standard closed drainage (-700 mmHg) following total knee arthroplasty.
| Condition | Intervention | Phase |
|---|---|---|
|
Total Knee Arthroplasty |
Device: low pressure suction drainage Device: High pressure suction drainage |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | "Low Versus High Pressure Suction Drainage After Total Knee Arthroplasty: a Double Blind Randomized Controlled Trial" |
Resource links provided by NLM:
Further study details as provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau:
Primary Outcome Measures:
- total post-surgical blood loss (mL) [ Time Frame: from the moment after surgery until drainage catheter removal ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- blood loss (mL) in the recovery unit [ Time Frame: 24-48 h ] [ Designated as safety issue: No ]
- Blood loss in the ward [ Time Frame: 5-10 days ] [ Designated as safety issue: No ]
- need for a blood transfusion according to the surgeon's criteria [ Time Frame: 10 days ] [ Designated as safety issue: No ]
- number of blood units required for transfusion [ Time Frame: 10 Days ] [ Designated as safety issue: No ]
- post-surgical pain (using a 100mm visual analogue scale) [ Time Frame: 10 days ] [ Designated as safety issue: No ]
- incidence of hematomas [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- infections [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- suture dehiscence [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- re-intervention due to complications in the surgical wound [ Time Frame: 10 dasy ] [ Designated as safety issue: Yes ]
- venous thrombosis [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- hypotension [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- mortality [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
- adverse reactions [ Time Frame: 10 days ] [ Designated as safety issue: Yes ]
| Enrollment: | 169 |
| Study Start Date: | May 2006 |
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Low suction drainage
In the experimental group the drainage catheter was connected to a modified DRENOFAST® system. This system consisted of a sterile plastic bottle with a holding capacity of 600 mL of fluid and a negative pressure of 700mmHg. It was hermetically closed and had two connections. The DRENOFAST® modification consisted of establishing an open connection between the bottle and a wall vacuum source (normally used to administer oxygen) placed next to the patient's bed. The 50 mmHg constant negative pressure of the bottle was maintained by the wall vacuum source and verified by flow meter.
|
Device: low pressure suction drainage
In the experimental group the drainage catheter was connected to a modified DRENOFAST® system. This system consisted of a sterile plastic bottle with a holding capacity of 600 mL of fluid and a negative pressure of 700mmHg. It was hermetically closed and had two connections. The DRENOFAST® modification consisted of establishing an open connection between the bottle and a wall vacuum source (normally used to administer oxygen) placed next to the patient's bed. The 50 mmHg constant negative pressure of the bottle was maintained by the wall vacuum source and verified by flow meter. Duration: Drains were removed after bleeding had ceased (48-72h).
Other Name: DRENOFAST® modified
|
|
Active Comparator: High suction drainage
The standard DRENOFAST® system was used in the control group, and the initial negative pressure was 700 mmHg.
|
Device: High pressure suction drainage
In order to mask the type of intervention from the patient and the investigators, both drainage systems had two drain catheters. One catheter allowed the blood to flow from the wound to the bottle. The second catheter connected the bottle to the vacuum source. In the experimental arm the second catheter was open, while in the control group it was closed. So that the system used could not be distinguished, the connection of the second catheter to the bottle was covered with opaque adhesive tape.Drains were removed after bleeding had ceased.
Other Name: DRENOFAST® system
|
Detailed Description:
Secondary's hypothesis:
It don't expect differences in:
- Incidence of hematomas
- Incidence in surgery wound infection
- Time of immobilization
- Duration of hospitalization
- The low suction drainage (-50 mmHg) will be more cost-effective than the standard closed drainage (-700 mmHg)
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Adult knee replacement patients who agreed to participate in the study
Exclusion Criteria:
- People that not accomplished the inclusion criteria
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00866268
Locations
| Spain | |
| Orthopedic and Traumatology Service. Hospital de la Santa Creu i Sant Pau. | |
| Barcelona, Catalunya, Spain, 08025 | |
| Hospital de la Santa Creu i Sant Pau | |
| Barcelona, Catalunya, Spain, 08025 | |
Sponsors and Collaborators
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Instituto de Salud Carlos III
Investigators
| Principal Investigator: | Calvo Rafael, Rn | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
More Information
No publications provided
| Responsible Party: | Rafa Calvo Oyón, Hospital de la Santa Creu i Sant Pau |
| ClinicalTrials.gov Identifier: | NCT00866268 History of Changes |
| Other Study ID Numbers: | DRENAJE50MMHG/1 |
| Study First Received: | March 19, 2009 |
| Last Updated: | March 19, 2009 |
| Health Authority: | Spain: Comité Ético de Investigación Clínica |
Keywords provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau:
|
Blood loss Total knee arthroplasty Adults Drain Drainage system |
ClinicalTrials.gov processed this record on May 23, 2013